WearLinq Acquires AMI Cardiac Monitoring to Expand Nationwide Clinical Services

May 21, 2024

WearLinq has acquired AMI Cardiac Monitoring, LLC to integrate AMI’s 33+ years of ambulatory cardiac monitoring expertise with WearLinq’s FDA 510(k)-cleared eWave 6-lead wearable ECG device. The acquisition expands WearLinq’s clinical services footprint across all 50 U.S. states and strengthens its diagnostic and remote-monitoring capabilities for cardiology providers and patients.

Buyers
WearLinq
Targets
AMI Cardiac Monitoring, LLC
Location
Maryland, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.